LENZ Therapeutics Statistics
NASDAQ: LENZHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
3.62-0.17 (-4.49%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
LENZ Therapeutics by the numbers
LENZ Therapeutics has a market capitalization of $113.7 million based on 31.42M shares outstanding. With trailing EPS of $-4.13, LENZ Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 23.3% below its 50-day average and 60.7% below its 200-day average.
Average daily trading volume is 838.15K shares, or about $3.0 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
LENZ valuation vs. peer median
| Metric | LENZ | Peer median | Difference |
|---|---|---|---|
| Market cap | $113.74M | $110.90M | +3% |
| Avg. volume | 838.15K | 700.96K | +20% |
Peer median across 8 companies: ENGN, TNYA, BDTX, HUMA, ATRA, CGTX, NMRA, ARMP.
Valuation
- Market cap
- $113.74M
- EPS (TTM)
- $-4.13
- Shares outstanding
- 31.42M
Price and trading
- Previous close
- 3.79
- Open
- 3.72
- Day range
- 3.59 – 3.72
- 52-week range
- 3.46 – 49.25
- 52-week change
- -92.29%
- Beta
- —
- Volume
- 515.17K
- Average volume
- 838.15K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 4, 2026
Additional statistics
- Market Cap
- 113.74M
- Forward Pe
- -1.18
- Eps
- -4.13
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 49.25
- Week52 Low
- 3.46
- Avg Volume
- 838.15K
- Shares Outstanding
- 31.42M
- Ma50
- 4.72
- Ma200
- 9.21
- Earnings Date
- Nov 4, 2026
- Pct From52w High
- -92.65%
- Pct From52w Low
- 4.78%